Finland reviewing pharma legislation
As a result of the change in Finland's constitution which took effect inMarch 2000, the country's Ministry of Social Affairs is proposing to revise pharmaceutical legislation. The plan is that authority for regulating pharmaceutical marketing will be transferred from the National Agency for Medicines to be governed by the Medicines Act and Decree. Additionally, changes of substances have been suggested to tighten up pharmaceutical marketing as well as the authorities' powers of inspection and information gathering.
The Pharma Industry Finland association has said that, while it appreciates that legislation is being adjusted to comply with the new constitution, it is of the opinion that the proposed restrictions on pharmaceutical marketing and investigation of trade secrets go against constitutional rights on freedom of expression and the protection of trade secrets.
Pharma sales grew 8.2% in 2000
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze